lundi 30 mars 2015

Oral drug normalizes blood potassium in 98 percent of kidney patients

A medication called ZS-9 normalized potassium in the blood of 98 percent of chronic kidney disease patients treated for hyperkalemia. Hyperkalemia is high potassium in the blood, and may occur as a side effect of taking kidney disease medications called Renin Angiotensin Aldosterone System inhibitors. Hyperkalemia increases the risk of cardiac arrhythmias.

Oral drug normalizes blood potassium in 98 percent of kidney patients

Aucun commentaire:

Enregistrer un commentaire